Christian Felder

Company: Karuna Therapeutics

Job title: Senior Scientific Fellow

Seminars:

Examining the Mechanisms of the Investigational Antipsychotic, KarXT 2:15 pm

Unveiling KarXT (xanomeline + trospium); an oral, investigational M1/M4-preferring muscarinic agonist in development for the treatment of psychiatric and neurological conditions, including schizophrenia and psychosis in Alzheimer’s disease Harnessing research which indicates that activity at M1 and M4 receptors indirectly affects dopamine neurotransmission in brain regions involved in mediating symptoms of serious mental illness, such…Read more

day: Day Two